How has Arcus Biosciences's prepaid expenses and other assets changed year-over-year?

Arcus Biosciences's prepaid expenses and other assets increased by 15.4% year-over-year, from $13M to $15M.

What is the long-term trend for Arcus Biosciences's prepaid expenses and other assets?

Over 3 years (2022 to 2025), Arcus Biosciences's prepaid expenses and other assets has grown at a -12.6% compound annual growth rate (CAGR), from $15M to $10M.

Arcus Biosciences RCUS Prepaid expenses and other assets

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.62B+226%

Enterprise value$3.53B+275%

P/S15.4×+7.5×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept rcus:PrepaidExpensesAndOtherCurrentAssets.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's prepaid expenses and other assets.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's prepaid expenses and other assets?: Arcus Biosciences (RCUS) reported prepaid expenses and other assets of $15M in Q1 2026.
How has Arcus Biosciences's prepaid expenses and other assets changed year-over-year?: Arcus Biosciences's prepaid expenses and other assets increased by 15.4% year-over-year, from $13M to $15M.
What is the long-term trend for Arcus Biosciences's prepaid expenses and other assets?: Over 3 years (2022 to 2025), Arcus Biosciences's prepaid expenses and other assets has grown at a -12.6% compound annual growth rate (CAGR), from $15M to $10M.